FundedIQ
Biotechnology

Biofire: Funding, Investors & Team (Oct 2026)

The goal of Biofire Technologies is to provide gun owners with better tools for decreasing avoidable gun injuries and fatalities, particularly in youngsters. We believe our technology will define the future of guns safety for the next generation when combined with the finest possible user experience. Our goal-driven strategy has gained the backing of the media, the tech industry, and the firearm community. World-class engineers working for Biofire have created and tested weapons, medical equipment, robotics, vehicles, satellites, rockets, and supersonic aircraft. Our team is united by our dedication to safety and dependability, which we bring to our work every day.

biofire.io LinkedIn Broomfield, United States 11-50 employees
Biometrics Consumer Electronics Public Safety Security B2B
Total raised
$14.0M
Rounds
1
Latest
Series A
Nov 2022

Biofire has raised $14.0M across 1 funding round on record, the most recent a Series A of $14.0M announced in Nov 2022.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Biofire Company Profile and Key Stats

Total funding raised
$14.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$14.0M in Nov 2022
Employees
11-50
reported band
Headquarters
Broomfield, United States

Latest funding round on record: Nov 2022.

Biofire Funding Rounds

Date
Round
Amount
Series A
$14.0M

Biofire Founders and Leadership Team

Name
Role
Contact
Kai Kloepfer
CEO
—

No contact details are on record for this team yet.

Biofire Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,234
$7.6M
8,558
$15M

Biofire's latest round of $14.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Biofire in Biotechnology and Broomfield

Companies Similar to Biofire

Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Biofire Funding FAQs

What does Biofire do?

The goal of Biofire Technologies is to provide gun owners with better tools for decreasing avoidable gun injuries and fatalities, particularly in youngsters. We believe our technology will define the future of guns safety for the next generation when combined with the finest possible user experience. Our goal-driven strategy has gained the backing of the media, the tech industry, and the firearm community. World-class engineers working for Biofire have created and tested weapons, medical equipment, robotics, vehicles, satellites, rockets, and supersonic aircraft. Our team is united by our dedication to safety and dependability, which we bring to our work every day.

How much funding has Biofire raised?

Biofire has raised $14.0M across 1 round on record. The most recent is a Series A of $14.0M announced in Nov 2022.

When did Biofire last raise funding?

Biofire's most recent funding round on record is a Series A of $14.0M, announced in Nov 2022.

Who is the CEO of Biofire?

Kai Kloepfer is listed as CEO at Biofire.

Where is Biofire headquartered?

Biofire is based in Broomfield, Colorado, United States.

How many employees does Biofire have?

Biofire is in the 11-50 employee band.

How does Biofire's funding compare to other Biotechnology startups?

Biofire's latest round of $14.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Biofire Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Biofire is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.